Table. Recommendations for meningococcal vaccines for groups at increased risk of meningococcal disease
'Special risk groups' include people with a specified medical condition associated with an increased risk of invasive meningococcal disease (see List. Specified medical conditions associated with increased risk of invasive meningococcal disease), laboratory workers at occupational risk of exposure to Neisseria meningitidis, and people aged 15–24 years who live in close quarters (such as new military recruits and students living in residential accommodation) or who are current smokers.
'Travellers' include people aged ≥2 months who are planning overseas travel to regions with an increased risk of exposure to meningococcal serogroups A, C, W or Y disease.
| Age group | Healthy Aboriginal and Torres Strait Islander people | Healthy non-Indigenous people | Special risk groups (including adolescent and young adult smokers and those living in close quarters; and laboratory workers) | Travellers to regions with an increased risk of exposure to MenACWY disease |
|---|---|---|---|---|
| 6 weeks–23 months | MenB and MenACWYa | MenB and MenACWYa | MenB and MenACWYa | MenACWYa |
| 2–14 years | MenB and MenACWY | None | MenB and MenACWY | MenACWY |
| 15–19 years | MenB and MenACWY | MenB and MenACWY | MenB and MenACWY | MenACWY |
| ≥20 years | None | None | MenB and MenACWY | MenACWY |
| a See brand specific recommendations. | ||||
Related diseases
Related chapters
Page history
Last updated
Last reviewed